Study explores the use of large language models (LLMs) like GPT-3.5 and GPT-4 in simulating diagnostic clinical reasoning, using diagnostic reasoning prompts to assess their capabilities.
Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate – Biotech Investments
EQS-News: Formycon AG / Key word(s): Regulatory Admission/Miscellaneous Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202,